Efficacy and safety of recombinant human activated protein for severe sepsis - Bernard, GR; Vincent, J-L; Laterre, P-F; for the Recombinant Human Activated Pro-tein C worldwide evaluation in severe sepsis (PROWESS) study group. (N Engl J Med, 2001)